This is a sidebar to CLP’s roundtable on The Value of Diagnostics, which includes Part 1, Part 2, and Part 3.
Chris Bird, DPhil, Roche Diagnostics Corp.
Chris Bird, DPhil, is head of medical and scientific affairs, North America, for Roche Diagnostics Corp., where he is responsible for clinical education, nonregistrational study management, and field support covering all Roche Diagnostics business areas. Before joining Roche, he was among the four original people at start-up molecular diagnostics company AutoGenomics.
Daniella Cramp, Alere.
Daniella Cramp, is global president, cardiometabolic, at Alere. In that role she focuses on cardiovascular and diabetes diagnostics and services across the entire continuum of care from the hospital to the home. She previously served as Alere’s global president of chronic care, and before that was vice president of the company’s cardiovascular business unit. Cramp joined Alere in June 2007 upon its acquisition of Biosite, where she was director of marketing.
Brian R. Jackson, MD, MS, ARUP Laboratories.
Brian R. Jackson, MD, MS, is vice president and chief medical informatics officer at ARUP Laboratories, and an associate professor of pathology (clinical) at the University of Utah. His research interests include economic analysis of diagnostic testing and physician utilization of laboratory tests. He is certified in clinical pathology by the American Board of Pathology.
Robert Jenison, Great Basin Scientific.
Robert D. Jenison, is senior vice president for R&D and chief technology officer at Great Basin Scientific. Jenison has been awarded 16 patents based on his work with nucleic acid ligands, arrayed elements, and novel molecular diagnostic testing approaches. Furthermore, his work has been published in numerous scientific journals. Jenison holds a bachelors degree in chemistry from Revelle College, at the University of California, San Diego.
Peter Koerte, PhD, Siemens Healthcare.
Peter Koerte, PhD, is president of point-of-care diagnostics at Siemens Healthcare. He previously served as Siemens’ vice president for point-of-care product life cycle management. Koerte holds a PhD in international management and business strategy from the Otto Beisheim School of Management, and a master’s degree in industrial engineering from Karlsruhe Institute of Technology.
Patrick R. Murray, PhD, BD Life Sciences.
Patrick R. Murray, PhD, is senior director of worldwide scientific affairs at BD Diagnostic Systems. Murray received his PhD in microbiology from UCLA. He is the former editor in chief of the ASM Manual of Clinical Microbiology and serves on numerous editorial boards. He has authored more than 275 research articles and 20 books.
Franz Walt, MBA, Siemens Healthcare.
Franz Walt, MBA, is president of laboratory diagnostics at Siemens Healthcare. Walt is a Swiss national with 26 years’ experience in the healthcare industry, including pharmaceuticals, medical devices, and diagnostics. He previously served 22 years with Roche, where he was for 8 years a member of the company’s global diagnostics executive committee.
Lâle White, MBA, Xifin.
Lâle White, MBA, is executive chairman and CEO of Xifin. A nationally recognized expert in the field of medical financial management and regulatory compliance, White is a member of the board of directors of bioTheranostics, part of the worldwide bioMerieux group, as well as a member of the board of directors of CombiMatrix Corp, a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders.
